Johnson & Johnson (J&J) is investing $1 billion in its MedTech business through an expansion of manufacturing, packaging, and distribution capabilities at its facility in Jacksonville, Florida, for its Acuvue contact lenses. The company’s MedTech business focuses on surgical, cardiovascular, orthopedic, and vision-care technologies. The investment is part of the company’s ongoing $55-billion US capital investment plan in manufacturing, research and development, and technology through early 2029. 

The $1-billion investment includes construction of a new distribution facility, alongside advanced manufacturing and packaging technologies, to expand capacity for its Acuvue contact lenses. Construction of the new facility is underway with the goal of being fully operational in 2028. 

Johnson & Johnson has two main business segments: Innovative Medicines, its pharmaceuticals business, which accounted for $60.4 billion of the company’s 2025 revenues, and MedTech, which accounted for $33.8 billion.  

Source: Johnson & Johnson